Wells Fargo’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Wells Fargo’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,190	Closed	-$35.7K	–	7739
2023 Q1	$35.7K	Hold	4,190	–	–	﹤0.01%	5347
2022 Q4	$36.3K	Buy	+4,190	New	+$33.7K	﹤0.01%	5005
2022 Q3	–	Sell	-189	Closed	-$1K	–	7725
2022 Q2	$1K	Sell	189 -1,100	-85%	-$5.92K	﹤0.01%	6687
2022 Q1	$6K	Sell	1,289 -1,615	-56%	-$8.44K	﹤0.01%	6445
2021 Q4	$14K	Sell	2,904 -1,000	-26%	-$4.93K	﹤0.01%	6447
2021 Q3	$30K	Buy	3,904 +208	+6%	+$1.78K	﹤0.01%	5826
2021 Q2	$43K	Buy	+3,696	New	+$56.1K	﹤0.01%	5625

Other funds holding VECT

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Versor Investments New York $59.8M AUM 85.83% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo's VECT Position: Q2 2023 in Review

Wells Fargo sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 4,190 shares — an estimated $35.7K sold.

Wells Fargo first reported a position in VECT in Q2 2021 and held it in 7 quarters. The position peaked at $43K in Q2 2021. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

Wells Fargo reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Wells Fargo sold 4,190 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $35.7K.
Wells Fargo first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 7 quarters.
Wells Fargo's VectivBio Holding AG Ordinary Shares position peaked at $43K in Q2 2021.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.